What was Taiwan Bio Therapeutics Co., Ltd.’s price range in the past 12 months?
Taiwan Bio Therapeutics Co., Ltd. lowest stock price was TWD 23.15 and its highest was TWD 30.50 in the past 12 months.
What is Taiwan Bio Therapeutics Co., Ltd.’s market cap?
Taiwan Bio Therapeutics Co., Ltd.’s market cap is TWD 2.29B.
When is Taiwan Bio Therapeutics Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Taiwan Bio Therapeutics Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Taiwan Bio Therapeutics Co., Ltd. pay dividends?
Taiwan Bio Therapeutics Co., Ltd. does not currently pay dividends.
What is Taiwan Bio Therapeutics Co., Ltd.’s EPS estimate?
Taiwan Bio Therapeutics Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Taiwan Bio Therapeutics Co., Ltd. have?
Taiwan Bio Therapeutics Co., Ltd. has 94,015,230 shares outstanding.
Which hedge fund is a major shareholder of Taiwan Bio Therapeutics Co., Ltd.?
Currently, no hedge funds are holding shares in TW:6892
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Taiwan Bio Therapeutics Co., Ltd.
Taiwan Bio Therapeutics Co., Ltd. is an enterprise specializing in regenerative medicine, primarily dedicated to the development of novel cellular therapeutics. These advanced treatments are crafted to address a range of medical conditions, including degenerative disorders, cardiovascular ailments, complications stemming from diabetes, and autoimmune diseases. The company was established in 2014 and its operations are headquartered in Taipei City, Taiwan.